Perceptive Advisors Turns Big Loss into Hefty Gain

Joseph Edelman’s biotech fund, whose performance landed him on the Rich List last year, was down by double digits this year but has since bounced back and then some.

joseph-edelman-article-size.jpg
Joseph Edelman, Perceptive Advisors (Bloomberg)

Now, this is what you call a comeback.

To continue reading, subscribe now to Premium Journalism. Already a subscriber? login.

Related